The IRCM Welcomes a World Leader in Biomedical Research
On November 12, 2026, the Montreal Clinical Research Institute (IRCM) had the privilege of hosting Professor Ravi "Kodi" Ravichandran, an internationally renowned scientist and a member of the Institute’s Scientific Advisory Board.
Recognized as one of the world's leading experts in the study of how the body clears apoptotic or dying cells, Dr. Ravichandran has helped transform the understanding of fundamental biological processes linked to immunity, cancer, and inflammatory diseases.
His visit is another illustration of the IRCM's prominent role within the international biomedical research ecosystem and the Institute's ability to attract world-class scientific talent. For nearly 60 years, the IRCM has drawn leading researchers from around the globe and cultivated close relationships with influential scientific leaders, strengthening its mission of innovation and excellence for the benefit of Quebec society.
“Visits such as these foster the exchange of groundbreaking ideas and allow our scientists to gain insight into research that may ultimately lead to entirely new therapeutic approaches,” said Dr. Jean-François Côté, President and Scientific Director of the IRCM.
Beyond his major scientific contributions, Dr. Ravichandran generously provides strategic insights to the IRCM through his role on the Scientific Advisory Board. His involvement helps ensure that the Institute remains at the forefront of advances in fundamental, translational, and clinical research.
By welcoming scientific leaders of this calibre, the IRCM reaffirms its commitment to remaining a globally recognized centre of excellence where the knowledge and innovations that will shape the medicine of tomorrow are being developed.
